J. Banchereau and R. Steinman, Dendritic cells and the control of immunity, Nature, vol.7, issue.6673, pp.245-52, 1998.
DOI : 10.1016/S1074-7613(00)80531-2

J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque et al., Immunobiology of Dendritic Cells, Annual Review of Immunology, vol.18, issue.1, pp.767-811, 2000.
DOI : 10.1146/annurev.immunol.18.1.767

W. Heath and F. Carbone, Dendritic cell subsets in primary and secondary T cell responses at body surfaces, Nature Immunology, vol.180, issue.12, pp.1237-1281, 2009.
DOI : 10.1084/jem.20041961

O. Joffre, E. Segura, A. Savina, and S. Amigorena, Cross-presentation by dendritic cells, Nature Reviews Immunology, vol.195, issue.8, pp.557-69, 2012.
DOI : 10.1084/jem.20011644

M. Haniffa, C. M. Ginhoux, and F. , Ontogeny and Functional Specialization of Dendritic Cells in Human and Mouse, Adv Immunol, vol.120, pp.1-49, 2013.
DOI : 10.1016/B978-0-12-417028-5.00001-6

F. Sallusto and A. Lanzavecchia, Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha, Journal of Experimental Medicine, vol.179, issue.4, pp.1109-1127, 1994.
DOI : 10.1084/jem.179.4.1109

URL : http://jem.rupress.org/content/jem/179/4/1109.full.pdf

E. Segura, M. Touzot, A. Bohineust, A. Cappuccio, G. Chiocchia et al., Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation, Immunity, vol.38, issue.2, pp.336-384, 2013.
DOI : 10.1016/j.immuni.2012.10.018

URL : https://doi.org/10.1016/j.immuni.2012.10.018

S. Jongbloed, M. Lebre, A. Fraser, J. Gracie, R. Sturrock et al., Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis, Arthritis Res Ther, vol.8, pp.10-1186, 1864.

F. Moret, C. Hack, K. Van-der-wurff-jacobs, W. De-jager, T. Radstake et al., Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity, Arthritis Research & Therapy, vol.15, issue.5, pp.10-4338, 1186.
DOI : 10.1016/j.bbrc.2007.03.081

R. Talotta, A. Berzi, F. Atzeni, A. Batticciotto, M. Clerici et al., Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response, Journal of Clinical Immunology, vol.20, issue.33, pp.550-557, 2015.
DOI : 10.1038/nm.3439

T. Tanaka, M. Narazaki, and T. Kishimoto, Therapeutic Targeting of the Interleukin-6 Receptor, Annual Review of Pharmacology and Toxicology, vol.52, issue.1, pp.199-219, 2012.
DOI : 10.1146/annurev-pharmtox-010611-134715

J. Müllberg, E. Dittrich, L. Graeve, C. Gerhartz, K. Yasukawa et al., Differential shedding of the two subunits of the interleukin-6 receptor, FEBS Letters, vol.31, issue.1-2, pp.174-182, 1993.
DOI : 10.1016/0165-2478(92)90138-E

D. Zohlnhöfer, L. Graeve, R. , S. Schooltink, H. Dittrich et al., The hepatic interleukin-6 receptor Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand, FEBS Letters, vol.139, issue.2-3, pp.219-241, 1992.
DOI : 10.1016/0092-8674(89)90607-7

T. Wang, G. Niu, M. Kortylewski, L. Burdelya, K. Shain et al., Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells, Nature Medicine, vol.191, issue.1, pp.48-54, 2004.
DOI : 10.1084/jem.191.3.541

C. Yu, D. Meyer, G. Campbell, A. Larner, C. Carter-su et al., Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein, Science, vol.269, issue.5220, pp.81-84, 1995.
DOI : 10.1126/science.7541555

F. Cheng, H. Wang, A. Cuenca, M. Huang, T. Ghansah et al., A Critical Role for Stat3 Signaling in Immune Tolerance, Immunity, vol.19, issue.3, pp.425-461, 2003.
DOI : 10.1016/S1074-7613(03)00232-2

URL : https://doi.org/10.1016/s1074-7613(03)00232-2

J. Melillo, L. Song, G. Bhagat, A. Blazquez, C. Plumlee et al., Dendritic Cell (DC)-Specific Targeting Reveals Stat3 as a Negative Regulator of DC Function, The Journal of Immunology, vol.184, issue.5, pp.2638-2683, 2010.
DOI : 10.4049/jimmunol.0902960

URL : http://www.jimmunol.org/content/jimmunol/184/5/2638.full.pdf

M. Buch, S. Bingham, D. Bryer, and P. Emery, Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders, Rheumatology, vol.46, issue.7, pp.1153-1159, 2007.
DOI : 10.1093/rheumatology/kem075

URL : https://academic.oup.com/rheumatology/article-pdf/46/7/1153/9449490/kem075.pdf

A. Isgren, K. Forslind, M. Erlandsson, C. Axelsson, S. Andersson et al., High Survivin Levels Predict Poor Clinical Response to Infliximab Treatment in Patients with Rheumatoid Arthritis, Seminars in Arthritis and Rheumatism, vol.41, issue.5, pp.652-659, 2012.
DOI : 10.1016/j.semarthrit.2011.08.005

M. Mihara, K. Kasutani, M. Okazaki, A. Nakamura, S. Kawai et al., Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family, International Immunopharmacology, vol.5, issue.12, pp.1731-1771, 2005.
DOI : 10.1016/j.intimp.2005.05.010

C. Garbers, N. Jänner, A. Chalaris, M. Moss, D. Floss et al., Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor Shedding, Journal of Biological Chemistry, vol.92, issue.17, pp.14804-14815, 2011.
DOI : 10.1523/JNEUROSCI.5221-09.2010

B. Betts, S. Angelo, E. Kennedy, M. Young, and J. , Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses, Blood, vol.118, issue.19, pp.5340-5343, 2011.
DOI : 10.1182/blood-2011-06-363390

URL : http://www.bloodjournal.org/content/bloodjournal/118/19/5340.full.pdf

P. Heinrich, I. Behrmann, G. Müller-newen, F. Schaper, and L. Graeve, Interleukin- 6-type cytokine signalling through the gp130, Jak/STAT pathway. Biochem J, vol.334, issue.2, pp.297-314, 1998.

S. Park, T. Nakagawa, H. Kitamura, T. Atsumi, H. Kamon et al., IL-6 Regulates In Vivo Dendritic Cell Differentiation through STAT3 Activation, The Journal of Immunology, vol.173, issue.6, pp.3844-54, 2004.
DOI : 10.4049/jimmunol.173.6.3844

URL : http://www.jimmunol.org/content/jimmunol/173/6/3844.full.pdf

D. Meley, D. Spiller, M. White, H. Mcdowell, B. Pizer et al., p53-mediated delayed NF-??B activity enhances etoposide-induced cell death in medulloblastoma, Cell Death & Disease, vol.3, issue.5, 2010.
DOI : 10.1038/msb.2010.6

URL : http://www.nature.com/cddis/journal/v1/n5/pdf/cddis201016a.pdf

M. Oukka, Th17 cells in immunity and autoimmunity, Annals of the Rheumatic Diseases, vol.67, issue.Suppl 3, pp.26-35, 2008.
DOI : 10.1136/ard.2008.098004

E. Böttger, G. De-carvalho, E. Meese, S. Kun, J. Esen et al., -Infected Erythrocytes, Journal of Interferon & Cytokine Research, vol.33, issue.2, pp.65-71, 2013.
DOI : 10.1089/jir.2012.0094

N. Honke, K. Ohl, A. Wiener, J. Bierwagen, J. Peitz et al., The p38-Mediated Rapid Down-Regulation of Cell Surface gp130 Expression Impairs Interleukin-6 Signaling in the Synovial Fluid of Juvenile Idiopathic Arthritis Patients, Arthritis & Rheumatology, vol.83, issue.Suppl 5, pp.470-478, 2014.
DOI : 10.1002/art.30570

E. Hidalgo, S. Essex, L. Yeo, S. Curnow, A. Filer et al., The response of T cells to interleukin-6 is differentially regulated by the microenvironment of the rheumatoid synovial fluid and tissue, Arthritis & Rheumatism, vol.48, issue.Suppl 2, pp.3284-93, 2011.
DOI : 10.1002/art.11160

X. Wang, T. Taga, K. Yoshida, M. Saito, T. Kishimoto et al., gp130, the cytokine common signal-transducer of interleukin-6 cytokine family, is downregulated in T cells in vivo by interleukin-6, Blood, vol.91, pp.3308-3322, 1998.

U. Weidle, S. Klostermann, D. Eggle, and A. Krüger, Interleukin 6/interleukin 6 receptor interaction and its role as a therapeutic target for treatment of cachexia and cancer, Cancer Genomics Proteomics, vol.7, pp.287-302, 2010.

R. and S. , The soluble interleukin-6 receptor and related proteins, Best Pract Res Clin Endocrinol Metab, vol.29, pp.787-97, 2015.

P. Xu and R. Derynck, Direct Activation of TACE-Mediated Ectodomain Shedding by p38 MAP Kinase Regulates EGF Receptor-Dependent Cell Proliferation, Molecular Cell, vol.37, issue.4, pp.551-66, 2010.
DOI : 10.1016/j.molcel.2010.01.034

H. Ying, L. Da, S. Yu-xiu, X. Yu, L. Li-xia et al., TLR4 Mediates MAPK???STAT3 Axis Activation in Bladder Epithelial Cells, Inflammation, vol.12, issue.3, pp.1064-74, 2013.
DOI : 10.1179/096805106X102255

C. Greenhill, R. , S. Lissilaa, R. Ferlin, W. Ernst et al., IL-6 Trans-Signaling Modulates TLR4-Dependent Inflammatory Responses via STAT3, The Journal of Immunology, vol.186, issue.2, pp.1199-208, 2011.
DOI : 10.4049/jimmunol.1002971

S. Fatima, Z. Khandekar, J. Parmentier, and K. Malik, Cytosolic phospholipase A2 activation by the p38 kinase inhibitor SB203580 in rabbit aortic smooth muscle cells, J Pharmacol Exp Ther, vol.298, pp.331-339, 2001.

T. Radstake, K. Nabbe, M. Wenink, M. Roelofs, A. Oosterlaar et al., Dendritic cells from patients with rheumatoid arthritis lack the interleukin 13 mediated increase of Fc??RII expression, which has clear functional consequences, Annals of the Rheumatic Diseases, vol.64, issue.12, pp.1737-43034405, 2004.
DOI : 10.1136/ard.2004.034405

V. Lutzky, S. Hannawi, and R. Thomas, Cells of the synovium in rheumatoid arthritis. Dendritic cells, Arthritis Research & Therapy, vol.9, issue.4, 2007.
DOI : 10.1186/ar2200

C. Richez, T. Barnetche, L. Khoryati, P. Duffau, M. Kostine et al., Tocilizumab Treatment Decreases Circulating Myeloid Dendritic Cells and Monocytes, 2 Components of the Myeloid Lineage, The Journal of Rheumatology, vol.39, issue.6, pp.1192-1199, 2012.
DOI : 10.3899/jrheum.111439

G. Jones, A. Sebba, J. Gu, M. Lowenstein, A. Calvo et al., Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study, Annals of the Rheumatic Diseases, vol.69, issue.01, pp.88-96105197, 2008.
DOI : 10.1136/ard.2008.105197

T. Tanaka, M. Narazaki, and T. Kishimoto, IL-6 in Inflammation, Immunity, and Disease, Cold Spring Harbor Perspectives in Biology, vol.6, issue.10, 2014.
DOI : 10.1101/cshperspect.a016295

URL : http://cshperspectives.cshlp.org/content/6/10/a016295.full.pdf